BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8751399)

  • 1. Fractionation in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):907-14. PubMed ID: 8751399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-dose-rate brachytherapy of cancer of the cervix: preliminary results of a prospectively designed schedule based on the linear-quadratic model.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Curochquin R
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1061-4. PubMed ID: 10192356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.
    Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R
    Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix.
    Patel FD; Negi PS; Sharma SC; Kapoor R; Singh DP; Ghoshal S
    Radiother Oncol; 1998 Dec; 49(3):317-23. PubMed ID: 10075265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer.
    Akagi Y; Hirokawa Y; Kagemoto M; Matsuura K; Ito A; Fujita K; Kenjo M; Kiriu H; Ito K
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):525-30. PubMed ID: 10078632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of linear-quadratic model in the treatment of cervical cancer using high-dose-rate brachytherapy.
    Sood B; Garg M; Avadhani J; Gorla G; Malhotra H; Guha C; Deore S; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1377-87. PubMed ID: 12459360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The irradiation tolerance dose of the proximal vagina.
    Au SP; Grigsby PW
    Radiother Oncol; 2003 Apr; 67(1):77-85. PubMed ID: 12758243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
    Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?
    Petereit DG; Pearcey R
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):359-66. PubMed ID: 10030262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.